Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2006 2
2010 1
2011 3
2013 4
2014 8
2015 6
2016 5
2017 9
2018 7
2019 8
2020 12
2021 14
2022 16
2023 26
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, Aricò M, Avcin T, Behrens EM, De Benedetti F, Filipovic L, Grom AA, Henter JI, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnik Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ; Paediatric Rheumatology International Trials Organisation; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society. Ravelli A, et al. Arthritis Rheumatol. 2016 Mar;68(3):566-76. doi: 10.1002/art.39332. Epub 2016 Feb 9. Arthritis Rheumatol. 2016. PMID: 26314788 Free article.
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial.
Ramanan AV, Quartier P, Okamoto N, Foeldvari I, Spindler A, Fingerhutová Š, Antón J, Wang Z, Meszaros G, Araújo J, Liao R, Keller S, Brunner HI, Ruperto N; JUVE-BASIS investigators; Paediatric Rheumatology International Trials Organisation. Ramanan AV, et al. Lancet. 2023 Aug 12;402(10401):555-570. doi: 10.1016/S0140-6736(23)00921-2. Epub 2023 Jul 6. Lancet. 2023. PMID: 37423231 Clinical Trial.
Organ-on-a-chip meets artificial intelligence in drug evaluation.
Deng S, Li C, Cao J, Cui Z, Du J, Fu Z, Yang H, Chen P. Deng S, et al. Among authors: li c. Theranostics. 2023 Aug 15;13(13):4526-4558. doi: 10.7150/thno.87266. eCollection 2023. Theranostics. 2023. PMID: 37649608 Free PMC article. Review.
The potential of plant extracts in cell therapy.
Li C, Cui Z, Deng S, Chen P, Li X, Yang H. Li C, et al. Stem Cell Res Ther. 2022 Sep 14;13(1):472. doi: 10.1186/s13287-022-03152-z. Stem Cell Res Ther. 2022. PMID: 36104798 Free PMC article. Review.
Early onset is an indication of the severity of DADA2 disease.
Zhao X, Zhang J, Li C, Kuang W, Deng J, Tan X, Li C, Li S, Wang J. Zhao X, et al. Among authors: li c. Rheumatology (Oxford). 2023 Feb 1;62(2):969-976. doi: 10.1093/rheumatology/keac233. Rheumatology (Oxford). 2023. PMID: 35471231 Review.
112 results